Similar articles

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.

  Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC, Hansson O; Alzheimer’s Disease Neuroimaging Initiative; Swedish BioFinder Study. Vogel JW, et al. Nat Commun. 2020 May 26;11(1):2612. doi: 10.1038/s41467-020-15701-2. Nat Commun. 2020. PMID: 32457389 Free PMC article.
• Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.

  Gibbons GS, Kim SJ, Wu Q, Riddle DM, Leight SN, Changolkar L, Xu H, Meymand ES, O'Reilly M, Zhang B, Brunden KR, Trojanowski JQ, Lee VMY. Gibbons GS, et al. Mol Neurodegener. 2020 Nov 4;15(1):64. doi: 10.1186/s13024-020-00404-5. Mol Neurodegener. 2020. PMID: 33148293 Free PMC article.
• Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

  Padmanabhan J, Levy M, Dickson DW, Potter H. Padmanabhan J, et al. Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20. Brain. 2006. PMID: 16987932
• Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.

  Morrone CD, Raghuraman R, Hussaini SA, Yu WH. Morrone CD, et al. Mol Neurodegener. 2023 Apr 21;18(1):27. doi: 10.1186/s13024-023-00617-4. Mol Neurodegener. 2023. PMID: 37085942 Free PMC article. Review.
• Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease.

  Zhang H, Cao Y, Ma L, Wei Y, Li H. Zhang H, et al. Front Cell Dev Biol. 2021 Jul 28;9:707268. doi: 10.3389/fcell.2021.707268. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34395435 Free PMC article. Review.